Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Albuterol Dose-Response on Pulmonary Function Testing in Preterm Infants at Risk of Bronchopulmonary Dysplasia

NCT02447250 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.

NCT NCT02447250
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02447250 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Albuterol Dose-Response on Pulmonary Function Testing in Preterm Infants at Risk of Bronchopulmonary Dysplasia
Lead sponsor
Oregon Health and Science University
Phase
Phase 4
Overall status
Completed
Start date
October 24, 2013
Completion date
December 30, 2014
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bronchopulmonary dysplasia, very low birth weight